Extracellular vesicle isolated from recombinant cells comprising polynucleotide encoding IL-1 blockade as target protein and use thereof
KR102191487B1
Microorganism capable of improving liver function or inhibiting fat accumulation and use thereof
KR20200140200A
Protein kinase inhibitor and use thereof
KR102136335B1
Microorganism capable of improving liver function or inhibiting fat accumulation and use thereof
KR102179480B1
Microorganism capable of degrading ethanol and acetaldehyde, method and kit for identifying the same
KR102179481B1
Microorganism capable of reducing lipid content, and method and kit for identifying the same
KR20190127559A
Extracellular vesicle isolated from recombinant microorganism comprising polynucleotide encoding target protein and use thereof
KR20200083816A
Microorganism expressing heterologous protein, and use thereof
KR20200083817A
Microorganism expressing heterologous protein, and use thereof
KR20200068263A
NY-ESO-1 Specific T Cell Receptor and Use Thereof
WO2020080560A1
Primer specific to non-toxic non-hemagglutinin protein gene sequence and use thereof
WO2020080561A1
Pluripotent stem cell culture medium and culture method using same
CN111328332A
Process for the preparation of bile acids
KR102015116B1
Extracellular vesicle isolated from recombinant microorganism comprising polynucleotide encoding target protein and use thereof
KR101880650B1
Microorganism capable of degrading ethanol and acetaldehyde, composition and kit comprising the same
KR101880651B1
Microorganism capable of degrading ethanol and acetaldehyde, composition and kit comprising the same
KR20190081942A
Microorganism expressing heterologous protein, and use thereof
KR101992345B1
Promoter polynucleotide, signal polypeptide and use thereof
KR20190076297A
MART-1 Specific T Cell Receptor and Use Thereof
WO2017204561A2
Recombinant polynucleotide coding for polypeptide comprising reporter moiety, substrate moiety and destabilizing moiety, host cell comprising same and use of same
